Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted Cohen

Showing results (41-50 of 300) with videos related to

Pageof 30
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Planning for the invisible: projecting resources needed to identify and treat all patients with MDR-TBCarole D Mitnick, Joel Keravec, Ted Cohen
American Journal of Respiratory and Critical Care Medicine|May 18, 2012
Linking surveillance with action against drug-resistant tuberculosisTed Cohen, Justin Manjourides, Bethany Hedt-Gauthier
Science Translational Medicine|September 27, 2013
Response to comment on "Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis"Harriet L Mills, Ted Cohen, Caroline Colijn
Plos Medicine|October 12, 2016
Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based AnalysisAmber Kunkel, Frank G Cobelens, Ted Cohen
The American Journal of Tropical Medicine and Hygiene|February 5, 2011
Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malariaBethany L Hedt, Miriam K Laufer, Ted Cohen
The Lancet. Infectious Diseases|August 2, 2018
Evidence sources on the natural history of latent tuberculosis infectionNicolas A Menzies, Ted Cohen, Joshua A Salomon
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 29, 2015
How could preventive therapy affect the prevalence of drug resistance? Causes and consequencesAmber Kunkel, Caroline Colijn, Marc Lipsitch, et al.
BMC Infectious Diseases|October 24, 2020
Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort studyPatrick George Tobias Cudahy, Douglas Wilson, Ted Cohen
BMJ (Clinical Research Ed.)|April 1, 2021
Test, trace, and isolate in the UKHao-Yuan Cheng, Ted Cohen, Hsien-Ho Lin
Plos Computational Biology|January 7, 2017
Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment StrategiesPia Abel Zur Wiesch, Fabrizio Clarelli, Ted Cohen
Pageof 30

Showing results (41-50 of 300) with videos related to

Sort By:
Pageof 30
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2013
Planning for the invisible: projecting resources needed to identify and treat all patients with MDR-TBCarole D Mitnick, Joel Keravec, Ted Cohen
American Journal of Respiratory and Critical Care Medicine|May 18, 2012
Linking surveillance with action against drug-resistant tuberculosisTed Cohen, Justin Manjourides, Bethany Hedt-Gauthier
Science Translational Medicine|September 27, 2013
Response to comment on "Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis"Harriet L Mills, Ted Cohen, Caroline Colijn
Plos Medicine|October 12, 2016
Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based AnalysisAmber Kunkel, Frank G Cobelens, Ted Cohen
The American Journal of Tropical Medicine and Hygiene|February 5, 2011
Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malariaBethany L Hedt, Miriam K Laufer, Ted Cohen
The Lancet. Infectious Diseases|August 2, 2018
Evidence sources on the natural history of latent tuberculosis infectionNicolas A Menzies, Ted Cohen, Joshua A Salomon
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 29, 2015
How could preventive therapy affect the prevalence of drug resistance? Causes and consequencesAmber Kunkel, Caroline Colijn, Marc Lipsitch, et al.
BMC Infectious Diseases|October 24, 2020
Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort studyPatrick George Tobias Cudahy, Douglas Wilson, Ted Cohen
BMJ (Clinical Research Ed.)|April 1, 2021
Test, trace, and isolate in the UKHao-Yuan Cheng, Ted Cohen, Hsien-Ho Lin
Plos Computational Biology|January 7, 2017
Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment StrategiesPia Abel Zur Wiesch, Fabrizio Clarelli, Ted Cohen
Pageof 30